Accretive Health
AH
AH was delisted on the 14th of March, 2014.
6 hedge funds and large institutions have $19.7M invested in Accretive Health in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
5% more capital invested
Capital invested by funds: $18.8M → $19.7M (+$868K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$2.83M |
| 2 |
LM
Litespeed Management
New York
|
+$2.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$575K |
| 2 |
Neuberger Berman Group
New York
|
-$123K |
AH Hedge Fund Activity: Q1 2016 in Review
6 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q1 2016, worth a combined $19.7M — up 4.6% from $18.8M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new AH positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was GMT Capital, opening a new position worth an estimated $2.83M. The largest seller was Paradigm Capital Management Inc, cutting an estimated $575K.
- 6 institutional investors held Accretive Health (AH) as of Q1 2016, up from 5 in Q4 2015.
- Funds reported $19.7M of Accretive Health stock for Q1 2016, up 4.6% quarter-over-quarter.
- 1 fund opened new Accretive Health positions in Q1 2016 and 0 closed out, a net change of +1 holder.
- The largest Accretive Health buyer in Q1 2016 was GMT Capital, an estimated $2.83M added.
- The largest Accretive Health seller in Q1 2016 was Paradigm Capital Management Inc, an estimated $575K sold.
Based on aggregated 13F filings for Q1 2016.